Skip to content
Stop using now Drug recall · FDA · Published October 1, 2019

New Vitalis Pharmacy Recalls Testosterone Injections Due to Lack of Sterility

New Vitalis Pharmacy recalls testosterone injections with lot numbers AL-07232019 to AL-09032019 due to lack of sterility assurance. Consumers should not use these products.

🇺🇸 FDA recall #D-0523-2020DrugNew Vitalis Pharmacy ›
Take action

Contact the company

Recalling firmNew Vitalis Pharmacy LLC dba New Vitalis Pharmacy4139 Cadillac Ct Ste 201 · Louisville, KY 40213-1578
✎ GovInfoNow plain-language explainer

New Vitalis Pharmacy is recalling testosterone injections that may not be sterile. This could cause infections or other health issues if used. The affected products have specific lot numbers and expiration dates. Read more at govinfonow.com/recall/37895-new-vitalis-pharmacy-recalls-testosterone-injections-due-to-lack-of.

Source Summary by GovInfoNow · govinfonow.com/recall/37895-new-vitalis-pharmacy-recalls-testosterone-injections-due-to-lack-of · Updated October 5, 2026 · FDA enforcement record: FDA #D-0523-2020

Cite this page

“New Vitalis Pharmacy Recalls Testosterone Injections Due to Lack of Sterility.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37895-new-vitalis-pharmacy-recalls-testosterone-injections-due-to-lack-of. Based on FDA recall #D-0523-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0523-2020%22&limit=1).

The FDA announced on Oct. 1, 2019, that New Vitalis Pharmacy LLC is voluntarily recalling Testosterone Cypionate/Testosterone Propionate Oil Injection Solution due to a lack of sterility assurance. The recall affects product distributed nationwide in the USA.

How to tell if you have it

  • Brand: New Vitalis Pharmacy
  • Product: Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial
  • Lot codes: AL-07232019@99 (exp 9-23-2019), AL-07312019@99 (exp 9-30-2019), AL-08132019@99 (exp 10-13-2019), AL-08272019@901 (exp 10-27-2019), AL-08282019@909 (exp 10-28-2019), Al-09032019@903 (exp 11-3-2019)
  • Quantity: 2981.62 mL
  • Distribution: Nationwide in the USA

The hazard

The product poses a hazard due to a lack of sterility assurance, according to the FDA.

Context

GovInfoNow's records show New Vitalis Pharmacy LLC has two other recalls on record since Sept. 22, 2021, including testosterone injections recalled on July 13, 2023, and testosterone vials recalled on Sept. 22, 2021, both due to lack of sterility assurance. Other recent recalls of similar products include New Life Pharma Semaglutide Injections Recall (Feb. 26, 2026), New Life Pharma Semaglutide Inj 2mg Vial Recall (Feb. 26, 2026), and New Life Pharma Tirzepatide Inj 15mg Vial Recall (Feb. 26, 2026).

How to tell if you have this one

Check the lot number on the vial, which starts with 'AL' followed by numbers and dates. The expiration dates range from September 23, 2019, to November 3, 2019.

  • Brand
    New Vitalis Pharmacy
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using It Now

    Immediately discard the recalled testosterone injections with lot numbers AL-07232019 to AL-09032019.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.4 years after the firm started it.

1. Firm started the recall: Oct 1, 201912. FDA classified it Class II: Nov 25, 201923. Published in FDA’s Enforcement Report: Dec 4, 201934. FDA terminated the recall: Mar 9, 2023420192023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What lot numbers are affected?

Lot numbers AL-07232019, AL-07312019, AL-08132019, AL-08272019, AL-08282019, and AL-09032019.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0523-2020 (October 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0523-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA